SARS-CoV-2 Omicron variant escapes neutralising antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents. Garcia-Valtanen et al
Published: 29 April 2022| Version 1 | DOI: 10.17632/mvkkvjbcsg.1
Contributor:
Pablo Garcia ValtanenDescription
Raw data from experimental results featured in: SARS-CoV-2 Omicron variant escapes neutralising antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents by Garcia-Valtanen et al
Files
Institutions
The University of Adelaide
Categories
COVID-19